Metformin inhibits the development, and promotes the resensitization, of treatment-resistant breast cancer
出版年份 2017 全文链接
标题
Metformin inhibits the development, and promotes the resensitization, of treatment-resistant breast cancer
作者
关键词
Cancer treatment, MTT assay, Breast cancer, Drug therapy, Mitochondria, Cancer prevention, Drug research and development, Histones
出版物
PLoS One
Volume 12, Issue 12, Pages e0187191
出版商
Public Library of Science (PLoS)
发表日期
2017-12-07
DOI
10.1371/journal.pone.0187191
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Regulation of organelle function by metformin
- (2017) Jeongho Kim et al. IUBMB LIFE
- Chidamide in the treatment of peripheral T-cell lymphoma
- (2017) Thomas Chan et al. OncoTargets and Therapy
- Deacetylase inhibitors: an advance in myeloma therapy?
- (2017) Jacob P. Laubach et al. Expert Review of Hematology
- Metformin in Lung Cancer: Review of in Vitro and in Vivo Animal Studies
- (2017) Michael Yousef et al. Cancers
- The energy disruptor metformin targets mitochondrial integrity via modification of calcium flux in cancer cells
- (2017) Camille Loubiere et al. Scientific Reports
- The hypoxic tumor microenvironment: A driving force for breast cancer progression
- (2016) Gregg L. Semenza BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Metformin Restrains Pancreatic Duodenal Homeobox-1 (PDX-1) Function by Inhibiting ERK Signaling in Pancreatic Ductal Adenocarcinoma.
- (2016) G. Zhou et al. CURRENT MOLECULAR MEDICINE
- Metformin inhibits growth of human non-small cell lung cancer cells via liver kinase B-1-independent activation of adenosine monophosphate-activated protein kinase
- (2016) QIANQIAN GUO et al. Molecular Medicine Reports
- Anticancer effect of metformin on estrogen receptor-positive and tamoxifen-resistant breast cancer cell lines
- (2016) JINKYOUNG KIM et al. ONCOLOGY REPORTS
- Biguanides sensitize leukemia cells to ABT-737-induced apoptosis by inhibiting mitochondrial electron transport
- (2016) Juliana Velez et al. Oncotarget
- Metformin therapy associated with survival benefit in lung cancer patients with diabetes
- (2016) Guoxing Wan et al. Oncotarget
- Oncogenic regulation of tumor metabolic reprogramming
- (2016) Míriam Tarrado-Castellarnau et al. Oncotarget
- Regulation of the breast cancer stem cell phenotype by hypoxia-inducible factors
- (2015) G. L. Semenza CLINICAL SCIENCE
- Endocrine therapy in premenopausal women with breast cancer: a critical appraisal of current evidence
- (2015) Filippo Montemurro et al. Expert Review of Anticancer Therapy
- Association between Metformin Therapy and Breast Cancer Incidence and Mortality: Evidence from a Meta-Analysis
- (2015) Ting Yang et al. Journal of Breast Cancer
- Changes in [18F]Fluoro-2-deoxy-d-glucose incorporation induced by doxorubicin and anti-HER antibodies by breast cancer cells modulated by co-treatment with metformin and its effects on intracellular signalling
- (2015) Alasdair C. Cooper et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- New trends for overcoming ABCG2/BCRP-mediated resistance to cancer therapies
- (2015) David Westover et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Histone Deacetylase Inhibitors in Clinical Studies as Templates for New Anticancer Agents
- (2015) Madhusoodanan Mottamal et al. MOLECULES
- Recent Advances in the Use of Metformin: Can Treating Diabetes Prevent Breast Cancer?
- (2015) Diana Hatoum et al. Biomed Research International
- Development, Maintenance, and Reversal of Multiple Drug Resistance: At the Crossroads of TFPI1, ABC Transporters, and HIF1
- (2015) Terra Arnason et al. Cancers
- Epigenetic reprogramming in breast cancer: From new targets to new therapies
- (2014) Tiffany A. Katz et al. ANNALS OF MEDICINE
- Metformin enhances tamoxifen-mediated tumor growth inhibition in ER-positive breast carcinoma
- (2014) Ji Ma et al. BMC CANCER
- Metformin and Cancer Risk and Mortality: A Systematic Review and Meta-analysis Taking into Account Biases and Confounders
- (2014) S. Gandini et al. Cancer Prevention Research
- Metformin: From Mechanisms of Action to Therapies
- (2014) Marc Foretz et al. Cell Metabolism
- Histone H2B monoubiquitination: roles to play in human malignancy
- (2014) Alexander J Cole et al. ENDOCRINE-RELATED CANCER
- Convergence of IPMK and LKB1-AMPK Signaling Pathways on Metformin Action
- (2014) Sookhee Bang et al. MOLECULAR ENDOCRINOLOGY
- Metformin reverses multidrug resistance in human hepatocellular carcinoma Bel-7402/5-fluorouracil cells
- (2014) SUNBIN LING et al. Molecular Medicine Reports
- Metformin—mode of action and clinical implications for diabetes and cancer
- (2014) Ida Pernicova et al. Nature Reviews Endocrinology
- TFPI1 Mediates Resistance to Doxorubicin in Breast Cancer Cells by Inducing a Hypoxic-Like Response
- (2014) Gerald F. Davies et al. PLoS One
- HIF-1α Inhibition Reverses Multidrug Resistance in Colon Cancer Cells via Downregulation of MDR1/P-Glycoprotein
- (2014) Jianfang Chen et al. PLoS One
- Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells
- (2014) Debangshu Samanta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effects of metformin on breast cancer cell proliferation, the AMPK pathway and the cell cycle
- (2013) S. M. Hadad et al. Clinical & Translational Oncology
- P-glycoprotein Inhibition as a Therapeutic Approach for Overcoming Multidrug Resistance in Cancer: Current Status and Future Perspectives
- (2013) Ziyad Binkhathlan et al. CURRENT CANCER DRUG TARGETS
- Metformin Synergistically Enhances Antitumor Activity of Histone Deacetylase Inhibitor Trichostatin A Against Osteosarcoma Cell Line
- (2013) Jian Duo et al. DNA AND CELL BIOLOGY
- Ferritin heavy chain as main mediator of preventive effect of metformin against mitochondrial damage induced by doxorubicin in cardiomyocytes
- (2013) Mari C. Asensio-Lopez et al. FREE RADICAL BIOLOGY AND MEDICINE
- Phosphorylation of Serine 399 in LKB1 Protein Short Form by Protein Kinase Cζ Is Required for Its Nucleocytoplasmic Transport and Consequent AMP-activated Protein Kinase (AMPK) Activation
- (2013) Huaiping Zhu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Understanding response and resistance to oestrogen deprivation in ER-positive breast cancer
- (2013) N. Patani et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Different Patterns of Akt and ERK Feedback Activation in Response to Rapamycin, Active-Site mTOR Inhibitors and Metformin in Pancreatic Cancer Cells
- (2013) Heloisa P. Soares et al. PLoS One
- Metformin Regulates Glucose Transporter 4 (GLUT4) Translocation through AMP-activated Protein Kinase (AMPK)-mediated Cbl/CAP Signaling in 3T3-L1 Preadipocyte Cells
- (2012) Jung Ok Lee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Effect of Three Decades of Screening Mammography on Breast-Cancer Incidence
- (2012) Archie Bleyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-estrogen resistance in breast cancer is induced by the tumor microenvironment and can be overcome by inhibiting mitochondrial function in epithelial cancer cells
- (2011) Ubaldo E. Martinez-Outschoorn et al. CANCER BIOLOGY & THERAPY
- Class IIa Histone Deacetylases Are Hormone-Activated Regulators of FOXO and Mammalian Glucose Homeostasis
- (2011) Maria M. Mihaylova et al. CELL
- Metformin Induces Both Caspase-Dependent and Poly(ADP-ribose) Polymerase-Dependent Cell Death in Breast Cancer Cells
- (2011) Y. Zhuang et al. MOLECULAR CANCER RESEARCH
- Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cells
- (2010) Mahvash Zakikhani et al. BREAST CANCER RESEARCH AND TREATMENT
- Metformin inhibits P-glycoprotein expression via the NF-κB pathway and CRE transcriptional activity through AMPK activation
- (2010) Hyung Gyun Kim et al. BRITISH JOURNAL OF PHARMACOLOGY
- Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
- (2010) A. DeCensi et al. Cancer Prevention Research
- Novel Assay of Metformin Levels in Patients With Type 2 Diabetes and Varying Levels of Renal Function: Clinical recommendations
- (2010) A. Frid et al. DIABETES CARE
- Troglitazone inhibits histone deacetylase activity in breast cancer cells
- (2009) G.F. Davies et al. CANCER LETTERS
- Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinib
- (2009) Henk J. Broxterman et al. DRUG RESISTANCE UPDATES
- PPARγ activation induces autophagy in breast cancer cells
- (2009) Jie Zhou et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Benzo(a)pyrene increases phosphorylation of p53 at serine 392 in relation to p53 induction and cell death in MCF-7 cells
- (2008) M. Tampio et al. TOXICOLOGY LETTERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started